Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...

The NHS has announced that the drug, abiraterone, will be offered to men with high-risk prostate cancer that has not yet ...

The NHS has announced that the drug, abiraterone, will be offered to men with high-risk prostate cancer that has not yet ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

A multitargeted T-cell therapy produced encouraging activity in a preliminary study of patients with pancreatic cancer, ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Real Housewives of Beverly Hills' Teddi Mellencamp said "everything’s good as it can be" amid her cancer battle after her ...

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...